Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnostic Chemicals Limited (DCL) was a prominent developer and manufacturer of diagnostic enzymes, clinical chemistry reagents, and specialty chemicals for the global healthcare and life sciences markets. Founded in 1970 and headquartered in Prince Edward Island, Canada, the company specialized in high-purity biochemicals and custom manufacturing services for diagnostic kit manufacturers. DCL's product portfolio included a wide range of assays for clinical chemistry, immunology, and molecular biology. The company was acquired by Genzyme Corporation in 2007 to strengthen its diagnostics business, and its operations were later integrated into Sekisui Diagnostics following Genzyme's divestiture of its diagnostics division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnostic Chemicals.